Skip to main navigation Investors & Media Contact Us Linkedin Twitter Overview News & Events Corporate Governance Financial Information Stock Information Investor Resources Analyst Coverage Barclays Peter Lawson, DPhil (Oxon) Cowen & Co. Yaron Werber, MD Goldman Sachs Corinne Jenkins H.C. Wainwright & Co. Robert Burns J.P. Morgan Anupam Rama Wedbush David Nierengarten, PhD SpringWorks Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding SpringWorks Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of SpringWorks Therapeutics or its management. SpringWorks Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Springworks - Toolkits Print Page Email Alerts RSS Feeds Investor Contacts Request E-mail Alerts Social Links linkedin twitter Who We Are Leadership & Board Mission & Values Partners & Collaborators Focus Areas Rare Oncology BCMA Combinations in Multiple Myeloma Biomarker-Defined Metastatic Solid Tumors Pipeline Nirogacestat Mirdametinib Clinical Trials Investigator-Initiated Research Careers View Opportunities Patients Desmoid Tumors NF1-PN Expanded Access Contact Investors & Media Press Releases Events & Presentations Corporate Governance Financial Information Stock Information Investor Resources © 2021 SpringWorks Therapeutics. All rights reserved. Copyright Links Privacy Policy Terms of Use

Investors & Media Contact Us Linkedin Twitter Who We Are Focus Areas Pipeline Patients Careers Investigator-Initiated Research We measure ourselves by the impact we have on people with cancer. Let’s continue to innovate. SpringWorks is committed to supporting Investigator-Initiated Research (IIR) to advance medical and scientiﬁc knowledge relating to its product candidates and current therapeutic areas of interest. Linkedin Twitter Who We Are Leadership & Board Mission & Values Partners & Collaborators Focus Areas Rare Oncology BCMA Combinations in Multiple Myeloma Biomarker-Defined Metastatic Solid Tumors Pipeline Nirogacestat Mirdametinib Clinical Trials Investigator-Initiated Research Careers View Opportunities Patients Desmoid Tumors NF1-PN Expanded Access Contact Investors & Media Press Releases Events & Presentations Corporate Governance Financial Information Stock Information Investor Resources © 2021 SpringWorks Therapeutics. All rights reserved. Privacy Policy Terms of Use By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies